Authors: | Hayase, E.; Hayase, T.; Mukherjee, A.; Stinson, S. C.; Jamal, M. A.; Ortega, M. R.; Sanchez, C. A.; Ahmed, S. S.; Karmouch, J. L.; Chang, C. C.; Flores, I. I.; McDaniel, L. K.; Brown, A. N.; El-Himri, R. K.; Chapa, V. A.; Tan, L.; Tran, B. Q.; Xiao, Y.; Fan, C.; Pham, D.; Halsey, T. M.; Jin, Y.; Tsai, W. B.; Prasad, R.; Glover, I. K.; Enkhbayar, A.; Mohammed, A.; Schmiester, M.; King, K. Y.; Britton, R. A.; Reddy, P.; Wong, M. C.; Ajami, N. J.; Wargo, J. A.; Shelburne, S.; Okhuysen, P. C.; Liu, C.; Fowler, S. W.; Conner, M. E.; Katsamakis, Z.; Smith, N.; Burgos da Silva, M.; Ponce, D. M.; Peled, J. U.; van den Brink, M. R. M.; Peterson, C. B.; Rondon, G.; Molldrem, J. J.; Champlin, R. E.; Shpall, E. J.; Lorenzi, P. L.; Mehta, R. S.; Martens, E. C.; Alousi, A. M.; Jenq, R. R. |
Article Title: | Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease |
Abstract: | Acute lower gastrointestinal GVHD (aLGI-GVHD) is a serious complication of allogeneic hematopoietic stem cell transplantation. Although the intestinal microbiota is associated with the incidence of aLGI-GVHD, how the intestinal microbiota impacts treatment responses in aLGI-GVHD has not been thoroughly studied. In a cohort of patients with aLGI-GVHD (n = 37), we found that non-response to standard therapy with corticosteroids was associated with prior treatment with carbapenem antibiotics and a disrupted fecal microbiome characterized by reduced abundances of Bacteroides ovatus. In a murine GVHD model aggravated by carbapenem antibiotics, introducing B. ovatus reduced GVHD severity and improved survival. These beneficial effects of Bacteroides ovatus were linked to its ability to metabolize dietary polysaccharides into monosaccharides, which suppressed the mucus-degrading capabilities of colonic mucus degraders such as Bacteroides thetaiotaomicron and Akkermansia muciniphila, thus reducing GVHD-related mortality. Collectively, these findings reveal the importance of microbiota in aLGI-GVHD and therapeutic potential of B. ovatus. Copyright © 2024 Elsevier Inc. All rights reserved. |
Keywords: | adult; middle aged; mouse; animal; animals; mice; hematopoietic stem cell transplantation; drug effect; mice, inbred balb c; mice, inbred c57bl; c57bl mouse; disease model; bagg albino mouse; graft versus host reaction; allogeneic hematopoietic stem cell transplantation; disease models, animal; intestine flora; microbiology; graft vs host disease; polysaccharides; feces; graft-versus-host disease; bacteroides; humans; human; male; female; dysbiosis; intestinal microbiome; gastrointestinal microbiome; akkermansia muciniphila; xylose; polysaccharide utilization loci; bacteroides thetaiotaomicron; akkermansia; bacteroides ovatus; mucus layer |
Journal Title: | Cell Host & Microbe |
Volume: | 32 |
Issue: | 9 |
ISSN: | 1931-3128 |
Publisher: | Cell Press |
Date Published: | 2024-01-01 |
Start Page: | 1621 |
End Page: | 1636 |
Language: | English |
DOI: | 10.1016/j.chom.2024.08.004 |
PUBMED: | 39214085 |
PROVIDER: | scopus |
PMCID: | PMC11441101 |
DOI/URL: | |
Notes: | Article -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PubMed and PDF -- MSK staff member Alan Hanash is thanked in the acknowledgements "... for serving as external advisory committeemember[s] of this work." -- Source: Scopus |